Body Composition and Characterization of Skinfold Thicknesses from Polycystic Ovary Syndrome Phenotypes: A Preliminary Case-Control Study

    March 2021 in “ International Journal of Environmental Research and Public Health ”
    María Luisa Sánchez-Ferrer, Ernesto de la Cruz Sánchez, Julián J. Árense-Gonzalo, María T. Prieto‐Sánchez, Itziar Bernabeu-González, Ana Carmona‐Barnosi, Jaime Mendiola, Alberto M. Torres‐Cantero
    This preliminary case-control study investigated body composition and skinfold thickness differences between women with polycystic ovary syndrome (PCOS) and those without, involving 266 women, 117 of whom were diagnosed with PCOS using the Rotterdam criteria. The study found that women with PCOS had a higher body mass index, fat mass percentage, and endomorphy component compared to controls. Each PCOS phenotype showed distinct somatochart representations, with the H-O-POM phenotype exhibiting significantly higher skinfold thicknesses and fat mass percentage than controls. These findings suggested that body composition differences in women with PCOS, particularly in the H-O-POM phenotype, could impact clinical evaluation and follow-up, highlighting the need for further research.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 21 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 year ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Sugar and Hair loss connections

      in Research/Science  41 upvotes 6 months ago
      High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.

      community C’est terrible - at my wits end

      in Female  450 upvotes 2 years ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

    Similar Research

    6 / 1000+ results